Filing Details

Accession Number:
0001384101-22-000046
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-07 16:34:18
Reporting Period:
2022-03-03
Accepted Time:
2022-03-07 16:34:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769333 C Giulia Kennedy 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Chief Scientific & Med Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-03 42,412 $0.00 79,987 No 4 A Direct
Common Stock Acquisiton 2022-03-04 4,407 $5.98 84,394 No 4 M Direct
Common Stock Disposition 2022-03-04 17,059 $24.91 67,335 No 4 S Direct
Common Stock Disposition 2022-03-04 5,844 $25.70 61,491 No 4 S Direct
Common Stock Disposition 2022-03-04 100 $26.49 61,391 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2022-03-03 77,287 $0.00 77,287 $26.02
Common Stock Stock Option (right to buy) Disposition 2022-03-04 4,407 $0.00 4,407 $5.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
77,287 2032-03-03 No 4 A Direct
0 2028-03-01 No 4 M Direct
Footnotes
  1. Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
  2. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
  3. Represents weighted average sales price. Sale prices for the transactions range from $24.40 to $25.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  4. Represents weighted average sales price. Sale prices for the transactions range from $25.41 to $26.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  5. The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
  6. The option is fully vested.